这些人很靠谱。一切都透明,报告定期送达,说到做到。没有隐藏信息,我查过
Palantir: The Stock Is Expensive, But The Growth Is Not Normal (NASDAQ:PLTR) | Seeking AlphaAurora Spine Corporation (ASG:CA) Shareholder/Analyst Call Prepared Remarks Transcript | Seeking AlphaGlobe Life: Quality Business, But The Easy Trust Recovery Is Already Priced In (NYSE:GL) | Seeking AlphaNorthern Mid Cap Index Fund Q1 2026 Commentary | Seeking AlphaHere is how Coinbase plan to survive the crypto winter by ditching its reliance on trading fees

Business
Investment Overview - Background To Today's News The stock of Amsterdam, Netherlands-based biotech uniQure N.V. (QURE) is soaring in trading today, owing to the FDA's latest volte face on what data the biotech may Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and…

business information
The key risks are valuation compression, commercial AIP growth slowdown especially if enterprise AI deployments take longer to convert into revenue. I am rating Palantir Technologies Inc. (PLTR) a Buy with a $183 price target. This represents a 41% upside potential from the current price of $130 as…
暂无文章
文章发表后将在此处显示。
